These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37787067)

  • 1. Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine.
    Domnich A; Amicizia D; Lai PL; Ogliastro M; Piedrahita-Tovar M; Orsi A; Icardi G; Panatto D
    Hum Vaccin Immunother; 2023 Aug; 19(2):2261689. PubMed ID: 37787067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season.
    Amicizia D; Domnich A; Lai PL; Orsi A; Icardi G; Tkach-Motulyak O; Panatto D
    Hum Vaccin Immunother; 2023 Dec; 19(1):2190279. PubMed ID: 36919537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax
    Lamb YN
    Drugs; 2019 Aug; 79(12):1337-1348. PubMed ID: 31372959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced passive safety surveillance of a quadrivalent inactivated split virion influenza vaccine in Finland during the influenza season 2020/21.
    Syrkina O; Inamdar A; Wague S; Monfredo C; Nissilä M; Chabanon AL; Serradell L
    BMC Public Health; 2022 Aug; 22(1):1506. PubMed ID: 35941631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced passive safety surveillance of Influvac® and Influvac® Tetra: Results from seven consecutive seasons.
    Moeller-Arendt M; van de Witte S; Nauta J; de Voogd H; Rogoll J; Nisslein T
    Vaccine; 2023 Jan; 41(2):606-613. PubMed ID: 36517322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season.
    Chabanon AL; Wague S; Moureau A; Nissila M; Serradell L
    BMC Public Health; 2021 Feb; 21(1):358. PubMed ID: 33588815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety Profile of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain: Passive Enhanced Safety Surveillance Study for the 2019/2020 Influenza Season.
    Salamanca de la Cueva I; Cinconze E; Eckermann T; Nwoji U; Godderis L; Lu E; Martínez-Gómez X; Wang H; Yanni E
    Drug Saf; 2021 Dec; 44(12):1375-1390. PubMed ID: 34694589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active surveillance for safety monitoring of seasonal influenza vaccines in Italy, 2015/2016 season.
    Spila Alegiani S; Alfonsi V; Appelgren EC; Ferrara L; Gallo T; Alicino C; Pascucci MG; Aquilani S; Spadea A; Tafuri S; Rizzo C
    BMC Public Health; 2018 Dec; 18(1):1401. PubMed ID: 30577729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season.
    Dos Santos G; Yeakey A; Shende V; Smith K; Lin F; Zandman-van-Dijk E; Damaso S; Schmidt A
    BMJ Open; 2019 Aug; 9(8):e028043. PubMed ID: 31427321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis.
    Dos Santos G; Shende V; Damaso S; Yeakey A
    Adv Ther; 2019 Dec; 36(12):3340-3355. PubMed ID: 31595482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.
    de Lusignan S; Dos Santos G; Byford R; Schuind A; Damaso S; Shende V; McGee C; Yonova I; Ferreira F
    Adv Ther; 2018 Aug; 35(8):1199-1214. PubMed ID: 29995300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A; Quinn H; Cashman P; Leeb A; Macartney K;
    Vaccine; 2017 Dec; 35(51):7101-7106. PubMed ID: 29128379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season.
    Grohskopf LA; Blanton LH; Ferdinands JM; Chung JR; Broder KR; Talbot HK; Morgan RL; Fry AM
    MMWR Recomm Rep; 2022 Aug; 71(1):1-28. PubMed ID: 36006864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A real-world study evaluating the relative vaccine effectiveness of a cell-based quadrivalent influenza vaccine compared to egg-based quadrivalent influenza vaccine in the US during the 2017-18 influenza season.
    Divino V; Krishnarajah G; Pelton SI; Mould-Quevedo J; Anupindi VR; DeKoven M; Postma MJ
    Vaccine; 2020 Sep; 38(40):6334-6343. PubMed ID: 32739119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brand-specific enhanced safety surveillance of GSK's Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season.
    de Lusignan S; Damaso S; Ferreira F; Byford R; McGee C; Pathirannehelage S; Shende V; Yonova I; Schmidt A; Schuind A; Dos Santos G
    Hum Vaccin Immunother; 2020 Aug; 16(8):1762-1771. PubMed ID: 32118513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season.
    Machado MAA; Gandhi-Banga S; Gallo S; Cousseau TG; Byrareddy RM; Nissilä M; Schelling J; Monfredo C
    Hum Vaccin Immunother; 2024 Dec; 20(1):2322196. PubMed ID: 38448394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient-reported outcome system for vaccine safety remote monitoring.
    Dos Santos G; Eckermann T; Martínez-Gómez X; Parra J; Nwoji U; Salamanca de la Cueva I
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13098. PubMed ID: 36991538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia.
    Pillsbury AJ; Glover C; Jacoby P; Quinn HE; Fathima P; Cashman P; Leeb A; Blyth CC; Gold MS; Snelling T; Macartney KK
    BMJ Open; 2018 Oct; 8(10):e023263. PubMed ID: 30341132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system.
    Betancourt-Cravioto M; Cervantes-Powell P; Tapia-Conyer R; Ledlie S; Gandhi-Banga S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1935170. PubMed ID: 34406896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial.
    Evans TG; Bussey L; Eagling-Vose E; Rutkowski K; Ellis C; Argent C; Griffin P; Kim J; Thackwray S; Shakib S; Doughty J; Gillies J; Wu J; Druce J; Pryor M; Gilbert S
    Lancet Infect Dis; 2022 Jun; 22(6):857-866. PubMed ID: 35305317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.